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There are two main types of layer V pyramidal neurons in rat cortex.
Type I neurons have tufted apical dendrites extending into layer I,
produce bursts of action potentials and project to subcortical targets
(spinal cord, superior colliculus and pontine nuclei). Type II neurons
have apical dendrites, which arborize in layers II–IV, do not produce
bursts of action potentials and project to ipsilateral and contralateral
cortex. The specific expression of different genes and proteins in
these two distinct layer V neurons is unknown. To distinguish
between distinct subpopulations, fluorescent microspheres were
injected into subcortical targets (labeling type I neurons) or primary
somatosensory cortex (labeling type II neurons) of adult rats. After
transport, cortical sections were processed for immunohistochem-
istry using various antibodies. This study demonstrated that antigens
recognized by SMI-32, N200 and FNP-7 antibodies were only
expressed in subcortical (type I) — but not in contralateral (type II)
— projecting neurons. NR1, NR2a/b, PLCβ1, BDNF, NGF and TrkB
antigens were highly expressed in all neuronal subpopulations exam-
ined. Organotypic culture experiments demonstrated that the devel-
opment of neurofilament expression and laminar specificity does not
depend on the presence of the subcortical targets. This study
suggests specific markers for the subcortical projecting layer V
neuron subpopulations.
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Introduction
The cerebral cortex is comprised of many different neuronal
types (Peters and Jones, 1985), which can be classified
according to distinct morphology, connectivity, and neuro-
chemical and electrophysiological characteristics; these char-
acteristics can be related to the laminar location of the cell
body. Although there is basic structural similarity across the
neocortex, specific functions are clearly localized to distinct
areas, which are characterized by microcircuitry, input and
output connectivity, local cytoarchitecture and proportions of
cell types (Brodmann, 1909). The subtle variations in cyto-
architecture reflect important differences in the computational
role of numerous cortical areas (Kaas, 1993). Although much
research has been conducted on brain development, funda-
mental questions remain about how specific neuronal
subpopulations differentiate and form functional circuits.
Layer V pyramidal neurons provide an excellent model for
addressing these important questions. In adult rodent cortex,
there are two major subpopulations of layer V pyramidal
neurons that have distinct projection targets, somatodendritic
morphologies and electrophysiological properties (Larkman
and Mason, 1990; Koester and O’Leary, 1992; Kasper et al.,
1994). Type I subcortical projecting neurons (projecting to the
spinal cord, superior colliculus and pontine nuclei) have tufted
apical dendrites terminating in layer I and fire bursts of action
potentials in response to depolarizing current. In contrast, type
II contralateral cortex projecting neurons have, non-tufted
apical dendrites, which arborize in layers II–IV and never fire
bursts of action potentials (Kasper et al., 1994). Our main ques-
tion is, are there molecules that characterize the different
somatodendritic morphologies of these two neuronal subpop-
ulations?
The aim of this study was to identify proteins that are differ-
entially expressed in layer V pyramidal neuron subpopulations
in the adult rat. Several proteins have been reported to be
strongly expressed in layer V, including: (i) neurotransmitter
receptors — N-methyl-D-aspartate receptor subunit 1 (NR1;
Aoki et al., 1994) and NR2a/b (Conti et al., 1999); (ii) neuro-
trophin receptors — tyrosine kinase receptor type B (TrkB;
Tongiorgi et al., 1999; Miller, 2000); (iii) neurotrophins —
nerve growth factor (NGF; Miller, 2000) and brain-derived
neurotrophic factor (BDNF; Murer et al., 1999); and (iv) neuro-
filaments — Sternberger monoclonal incorporated antibody 32
(SMI-32; Hof et al., 1995; Gabernet et al., 1999), medium-sized
neurofilament clone (FNP-7; Hornung and Riederer, 1999) and
neurofilament 200 (N200; Sasaki and Maruyama, 1994).
However, these studies did not investigate the protein expres-
sion in layer V pyramidal neuron subpopulations based on
axonal projection. Therefore, for most of these proteins, it is
not clear if all — or only a subset of pyramidal cells — express
these molecules. The medium-sized neurofilament proteins
(SMI-32, N200 and FNP-7) were of particular interest because
previous studies in primate (monkey and human) have shown
that these proteins are expressed in ∼30% of cortical pyramidal
neurons (Campbell et al., 1991; Hof and Morrison, 1995; Hof et
al., 1996b; Bussière et al., 2003a). These studies have
described the overall regional and laminar distributions of cells
containing these neurofilaments, but have only examined corti-
cocortical neurons. This paper further characterizes the
neuronal pyramidal populations that express these neurofila-
ment proteins by examining not only the corticocortical — but
also the subcortical — projecting neurons in layer V. The only
layer V pyramidal cell subpopulation marker identified is the
transcription factor Otx1, which is specific for subcortical
projecting neurons (Weimann et al., 1999). In this study, layer
V pyramidal neurons were divided into subpopulations based
on their axonal projection site, which were identified by retro-
grade labeling. Immunohistochemistry was then used to screen
the identified subpopulations using a panel of antibodies
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against proteins expressed in layer V. Three proteins were
identified that are selectively expressed in subcortical
(superior colliculus and spinal cord projecting type I neurons)
— but not contralateral cortex (type II neurons) — projecting
layer V pyramidal neurons in adult rats. Their specific and
selective expression pattern was maintained in early postnatal
cortical slice cultures, suggesting that the development and
maintenance of these neurofilament protein expression
patterns are not dependent on their target.
Materials and Methods
Animals
Nine young adult wistar rats (120–180 g) were used for this study
(n = 3, cortical injections; n = 3, spinal cord injections; n = 3, superior
colliculus injections). Embryonic day 16 (E16) rats (n = 11) and post-
natal day 4 (P4) rats (n = 12) were used for the organotypic cultures.
All experimental protocols were approved by and in accordance with
the regulations and guidelines of the University of Oxford (UK), the
Home Office (UK) and the University of Lausanne (Switzerland).
Retrograde Tracing with Fluorescent Latex Microspheres
Green fluorescent latex microspheres (Lumafluor, Naples, FL) were
used to identify subpopulations of cortical layer V pyramidal cells
based on their axonal targets.
Adult rats were anesthetized with 2.7 mg/kg Hypnovel (Roche,
Basel, Switzerland), Hypnorm (Janssen, Titusville, NJ) and distilled
H2O (1:1:2 volume ratio), which was delivered i.p. and placed in a
stereotaxic frame. After the skin was disinfected and incised, a micro-
drill was used to perform a craniotomy. Glass micropipettes (Clark
Electromedical Instruments, Reading, UK) and a binocular stereo-
microscope (Zeiss, Germany) were used to inject 0.3–1.0 µl of micro-
spheres into one of three pyramidal cell targets: primary somatosen-
sory cortex (n = 3; 3.0 mm posterior to bregma, 3.5 mm lateral of
sagittal suture, 1 mm deep; Welker et al., 1996), superior colliculus
(n = 3; 6.5 mm posterior to bregma, 1.5 mm lateral of sagittal suture,
3.5 mm deep; Paxinos et al., 1985) or spinal cord [n = 3; between
thoracic 1 (T1) and (T2)]. Each target received two or three injections
∼100 µm from each other. The micropipette was kept in place for
1–2 min before retraction. During the postoperative period, animals
were kept under a heating lamp before returning them to their cages.
All animals recovered quickly and resumed normal behavior following
the procedure. Animals were allowed to survive for 24–48 h to permit
adequate retrograde transport of the microspheres to the pyramidal
soma (Fig. 1A). For the organotypic culture experiments, P3 rats were
anesthetized by hypothermia and injections into either the somatosen-
sory cortex (n = 6; 2 mm posterior to bregma, 2–3 mm lateral of
sagittal suture, approximately 150–200 µm deep) or the center of the
superior colliculus (n = 6; under direct visual guidance since it is not
yet covered by the occipital pole of the cortex) were made. The rest
of the retrograde-labeling procedure for P3 animals followed the adult
protocol above.
Immunohistochemistry
After 1–2 days, animals were anesthetized with sodium pento-
barbitone (25 mg/kg) delivered i.p. and perfused transcardially with
cold saline followed by 4% paraformaldehyde in 0.1 M phosphate
buffer (PB; pH 7.4). Brains were removed and post-fixed for 6 h to
overnight in 4% paraformaldehyde in 0.1 M PB (pH 7.4) at 4°C. Brains
were sectioned at 60 µm in the coronal plane using a vibroslicer
(VT1000S; Leica, Heidelberg, Germany) and serial sections through
the primary somatosensory and motor cortices were collected. Free-
floating sections were washed in 0.05 M tris buffer containing 0.9%
NaCl (TBS; pH 7.4) and incubated for 2 h in TBS containing 10%
normal goat serum (NGS) and 0.1% Triton X-100 to mask non-specific
binding sites. Sections were then incubated overnight in the primary
antibody diluted in TBS containing 1% NGS and 0.1% Triton X-100 (see
Table 1 for dilutions). After rinsing in TBS, sections incubated with
polyclonal primary antibodies were further incubated in cyanine
(CY3)-conjugated goat anti-rabbit (Jackson Immunoresearch Labora-
tories, West Grove, PA) in TBS with 1% NGS for 2 h (see Table 1 for
dilutions). Sections incubated with monoclonal primary antibodies
(Table 1) were initially incubated in biotinylated-conjugated goat anti-
mouse antibody (Vector Laboratories, Burlingame, CA) in TBS with 1%
NGS (all diluted 1:100) for 2 h, rinsed in TBS and incubated in CY3-
conjugated to streptavidin (Jackson Immunoresearch Laboratories,
West Grove, PA) for 2 h (all diluted 1:500). After a final rinse in TBS,
sections were counterstained with bisbenzimide Hoechst trihydro-
chloride (2.5 µg/ml PBS; Sigma-Aldrich, St Louis, MO), mounted on
gelatin-coated slides, air-dried and cover slipped with PBS. Slides were
stored in 4°C and protected from light. The immunohistochemistry
controls were negative (data not shown).
Organotypic Cortical Cultures
To determine if targets of layer V pyramidal neurons are responsible
for the maintenance and the selective expression of neurofilament
antigens, two types of organotypic culture experiments were
performed (Fig. 1B,C).
Cortical slices were prepared from the parietal cortex of E16 rats
(n = 11) and maintained for 2 weeks in culture conditions according
to the methods described in Molnár and Blakemore (1991, 1999; see
also Fig. 1B). A tissue chopper was used to cut 350 µm thick cortical
slices from E16 rats. The tissue blocks were transferred to a Petri dish
containing Hanks balanced salt solution (Sigma) supplemented with
glucose to a final concentration of 6.5 mg/ml. Explants were then
placed on Transwell-COL culture chamber membranes (pore size
0.4 µm, 24.5 mm diameter inserts; Costar, Cambridge, MA). Cultured
explants were maintained in N2 medium [1:1 mixture of Dulbecco’s
modified Eagle’s medium (DMEM) and Ham’s F12, supplemented with
insulin (5 µg/ml), transferrin (100 µg/ml), progesterone (20 nM),
putrescine (100 mM) and selenium (30 nM, as Na2SeO4)]. These
constituents were made up into stock solutions, filter-sterilized (pore
size 0.2 µm) and then added to the medium individually. In most
cases, we used N2 stock solution (Gibco BRL, Grand Island, NY). The
Figure 1. Schematic representation of fluorescent latex microsphere injection and co-
culturing methods. (A) Fluorescent microsphere injection locations into the (a) adult rat
spinal cord, (b) superior colliculus, or (c) contralateral cortex. Microspheres were
retrogradely transported from the target tissue location to the cell bodies of layer V
pyramidal neurons. Brains were sectioned coronally and prepared for
immunohistochemistry with the various antibodies tested. (a′) Bilateral distribution of
layer V spinal cord projecting neurons. (b′) Location of layer V neurons projecting to the
ipsilateral superior colliculus. (c′) Distribution of the contralateral cortex projecting
neurons, which were located in all layers except layer I. Layers II, III and V showed a
particularly strong labeling. (B) Cortical sections were cultured from E16 rats for 2
weeks. Sections were then fixed in 4% paraformaldehyde and then immunostained
with SMI-32 and FNP-7. (C) Layer V neurons were pre-labeled before culturing.
Microsphere injections were made into the (a) superior colliculus or (b) contralateral
cortex of P3 animals. Cortical slices containing back-labeled layer V neurons were
cultured at P4 for 2 weeks, fixed and immunostained with SMI-32 and FNP-7 as in B.
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cultures were maintained in Transwell-COL culture chambers (Costar)
under standard culturing conditions with continuous flow of humidi-
fied carbogen (5% CO2 and 95% air, 100% humidity, 40°C) in a
modular incubator chamber (Flow Laboratories). After culturing, the
slices were fixed in 4% paraformaldehyde in 0.1 M PB (pH 7.3) and the
entire slice (without resectioning) was immunostained using SMI-32
and FNP-7 antibodies (for details, see above).
Organotypic culture experiments with cortical slices containing
pre-labeled pyramidal cells were used to examine whether the
subpopulations of layer V neurons maintain their antigenicity in the
absence of the target tissue (Fig. 1C). At P3, after the corticofugal
projections have reached the superior colliculus and the contralateral
cortex, fluorescent latex microspheres were injected under direct
visual guidance into either the somatosensory cortex or the superior
colliculus in rats as described above. At P4, animals were anesthetized
by hypothermia and cortical slice cultures (40 slices in total) were
prepared (Porter et al., 1999) from regions containing labeled cells
(Fig. 1C). The brains were quickly removed from the skull and placed
into cold, sterile MEM (Life Technologies, Gaithersburg, MD) with
200 mM Tris buffer (dissecting medium). A McIlwain tissue chopper
was used to cut sections at a thickness of 250 µm and placed into
dissecting medium. The slices were then placed into a Millicell-CM
(Millipore, Bedford, MA) insert that was immersed in dissecting
medium. Dissecting medium was replaced with culture medium,
which included: DMEM supplement with 25% normal horse serum
(NHS; Life Technologies) and 20 nM glutamine. Medium levels were
maintained so that there was an air-medium interface. Medium was
refreshed every 2–3 days by removing half the volume and replacing
it with fresh medium. Slices were cultured for 2 weeks after which
they were fixed and immunostained without resectioning using FNP-7
and SMI-32 (see above). Individual microsphere-labeled layer V
neurons were examined for immunohistochemistry using fluores-
cence and confocal laser scanning microscopy.
Quantification of Double-labeled Cells using Fluorescence 
Microscopy
Immunolabeled sections from adult, embryo and neonate animals
were analyzed with a Leitz Diaplan fluorescence microscope (Wetzlar,
Germany) equipped with appropriate barrier filters for the various
fluorophores. Quantification of double-labeled cells was restricted to
the somatosensory cortex for superior colliculus and contralateral
cortex projecting cells and to the motor cortex for the spinal cord
projecting neurons. Two to three cortical sections for each injection
paradigm were selected that contained numerous fluorescent back-
labeled pyramidal cells within S1 and M1. All layer V pyramidal
neurons per section that contained fluorescent microspheres were
examined for immunostaining by changing the fluorescence filter
under 100× oil immersion objective. True color images were captured
using a Leica DC 500 digital camera (Leica, Bensheim, Germany). The
present study is based on the examination of 6501 layer V pyramidal
neurons. An average of 240 cells per layer V subpopulation was
counted for each antibody (n = 9) used. All layer V neurons per post-
natal organotypic culture that contained fluorescent microspheres
were examined for neurofilament immunoreactivity. In total, 40
cultures were prepared from somatosensory cortex injections (n = 6
rats; SMI-32 = 320 cells counted; FNP-7 = 286 cells counted) and supe-
rior colliculus injections (n = 6 rats; SMI-32 = 196 counted; superior
colliculus = 361 cells counted).
Statistical Analysis
A total of nine adult rats were used for the immunohistochemical and
back-labeling protocol (Fig. 1A); three for each injection paradigm
(n = 3, somatosensory cortex; n = 3, superior colliculus; n = 3, spinal
cord). A total of 12 P3 rats were used for the culture experiments
(Fig. 1B,C); six for each injection paradigm (n = 6, somatosensory
cortex; n = 6, superior colliculus). The percentage of double-labeled
cells identified relative to the total number of cells counted (fluor-
escent-labeled only plus double-labeled) was calculated for each
animal. Percentages for each subpopulation (contralateral cortex,
superior colliculus or spinal cord projecting cells) were compared for
each antibody using a student’s t-test, with P < 0.05 being considered
statistically significant.
Confocal Microscopy
Laser-scanning confocal microscopy (Leica TCS NT, Germany) vali-
dated the quantification conducted under the fluorescence micro-
scope. Excitation was obtained with an argon–krypton laser, with
lines set at 488 nm for fluorescein isothiocyanate (FITC) and 568 nm
for tetramethyl rhodamine isothiocyanate (TRITC). Between six and
eight optical sections (z distance between each: 0.2–0.5 µm) were
scanned through a single pyramidal cell. Images were taken in a 1024
× 1024 pixel format using a 100×/1.4 N.A. oil immersion objective.
Individual optical sections and the Z-axis reconstructions were exam-
ined before images were compiled into a single image. The single
images were then processed using Adobe Photoshop 6.0.
Table 1
Sources, technical details and concentrations of antibodies used
Abbreviations: BDNF, brain derived neurotrophic factor; bGM, biotinylated goat anti-mouse antibody; C.I.I. Chemicon International Inc.; Cy3-R, Cy3 goat anti-rabbit antibody; Cy3-St, Cy3 goat anti-
streptavidin antibody; FNP-7, medium-sized neurofilament clone; M, mouse; mAb, monoclonal antibody; N200, neurofilament 200 kDa; NF, neurofilament; NGF, nerve growth factor; NMDA, N-methyl-D-
aspartate; NR1, N-methyl-D-aspartate receptor subunit 1; NR2a/b, N-methyl-D-aspartate receptor subunit 2a/b; pAb, polyclonal antibody; PAb, primary antibody; PLCb1, phospholipase C isoenzyme beta1; 
R, rabbit; S.A. Sigma-Aldrich Corp. (St Louis, MO); S.C.B.I. Santa Cruz Biotechnology Inc. (Santa Cruz, CA); S.M.I. Sternberger Monoclonal Inc. (Lutherville, MD); SMI-32, Sternberger Monoclonal Inc. 
antibody 32; TrkB, tyrosine protein kinase receptor type B (Temecula, CA); V.L. Virginia Lee (Philadelphia, PA).
Antigen Source Type Specificity Dilutions 
PAb bGM Cy3-St Cy3-R
NR1 C.I.I. R IgG pAb R1-1a, -1b, -2a, -2b subunits of the NMDA receptor 1:500 1:100
NR2a/b C.I.I. R IgG pAb R2a and R2b subunits of the NMDA receptor 1:1000 1:500
PLCb1 S.C.B.I. R IgG pAb PLCb1 enzyme of the PLC isoenzyme family 1:1000 1:100
BDNF S.C.B.I. R IgG pAb Amino terminus of BDNF 1:500 1:100
NGF S.C.B.I. R IgG pAb Amino terminus of NGF 1:1000 1:500
TrkB S.C.B.I. R IgG pAb TrkB receptor of the Trk family 1:200 1:500
SMI-32 S.M.I. M IgG mAb Non-phos. NF-H (200 kDa) 1:5000 1:100 1:500
N200 S.A. M IgG mAb Phos. and non-phos. NF-H (200 kDa) 1:400 1:100 1:500
FNP-7 V.L. M IgG mAb Non-phos. NF-M (150 kDa) 1:1200 1:100 1:500
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Results
Distribution of Labeled Cells from the Fluorescent 
Microsphere Injections into Different Pyramidal Cell 
Targets
Spinal Cord Projecting Neurons
Spinal cord injections (Fig. 2A) revealed retrogradely labeled
cells in the somatosensory and motor cortices (Fig. 2B,C). Cells
were more numerous in the dorso-medial part of the frontal
poles. The labeled neurons were limited to layer V (Fig. 2B,D).
The soma size of the spinal cord projecting neurons appeared
similar to that of the superior colliculus projecting neurons,
both of which were larger than those projecting to the contral-
ateral hemisphere (Fig. 2C,G,K).
Superior Colliculus Projecting Neurons
All cells labeled after superior colliculus injections (Fig. 2E)
were located exclusively in layer V (Fig. 2F,H). The majority of
back-labeled cells were found in the upper part of layer V. A
minority of labeled cells were scattered in the lower portion of
layer V as well; however, no sharp boundary between the
upper and lower layer V cells was observed. The band of
labeled cells extended throughout the primary somatosensory
cortex, while more posterior regions (i.e. occipital cortex)
contained a slightly greater number of labeled neurons.
Contralateral Cortex Projecting Neurons in the Primary
Somatosensory Area
Although it is known that primary cortical areas have fewer
callosal connections (Akers and Killackey, 1978), numerous
contralateral projecting neurons were found in the primary
somatosensory cortex after cortical injections (Fig. 2I). The
labeled cells were distributed in all cortex layers, with the
exception of layer I (Fig. 2J,L). Layers II, III and V had the
greatest number of labeled cells, whereas layer IV contained
relatively few labeled cells. The callosal projecting neurons
were smaller than the spinal cord or superior colliculus
projecting neurons (Fig. 2K).
Immunohistochemical Analysis of Layer V Projection 
Neuron Subpopulations
Markers Ubiquitously Expressed in all Three Subpopulations
Examined
Most neurons in the neocortex were stained with the antibody
against the glutamate receptor, NR-1. However, layers II, III, V
and VI contained especially large numbers of heavily labeled
cells bodies. The apical dendrites, as well as some parts of the
terminal tufts, exhibited strong immunoreactivity. NR2a/b was
also expressed in all cortical layers, with cell bodies most
strongly labeled in layers II–V. Similar to NR-1 staining, NR2a/b
also stained the proximal dendrites. The isozyme, phospho-
lipase Cβ1 (PLCβ1) was diffusely expressed in layers II, III, IV, V
and VI on neuronal apical dendrites. Staining for the neuro-
trophin BDNF showed expression in cortical layers II, III, V
and VI throughout the cortex with labeling of the soma, prox-
imal dendrites and axons of pyramidal cells. NGF was
expressed in almost every cell in the cortex with a particularly
high density in layers II, III and V. Pyramidal cell bodies and
dendrites were most strongly immunolabeled. The BDNF
receptor, TrkB was expressed in large numbers of neurons in
all cortical layers. Layers V and VI contained the greatest
number of immunoreactive cells. Only the initial segment of
the layer V neuronal apical dendrites and primary dendrites
were labeled. The apical dendrites and the apical tufts were
not immunoreactive for TrkB.
Markers Specific for Subcortical Projecting Pyramidal
Neurons (SMI-32, FNP-7 and N200)
SMI-32, which reacts with non-phosphorylated epitopes in
neurofilament-M (150 kDa) and -H (200 kDa; Lee et al., 1988),
was intensely expressed in the cortical white matter. Layers II,
III and V cells were strongly stained in the medial somato-
sensory cortex; however, the immunoreactivity in layers II and
III decreased when progressing laterally, while layer V staining
remained the same (Fig. 3A,B). SMI-32 was expressed in the
soma and the dendrites, but only some thick axons of pyra-
midal neurons (Fig. 3C,D). FNP-7, which reacts exclusively
with non-phosphorylated NF-M, is most prominently
expressed in layers III, V and VI (Fig. 3E,F). FNP-7 also stained
the somata and apical and basal dendrites, as well as the prox-
imal axon extending into the white matter (Fig. 3G,H). N200,
which reacts with both the phosphorylated and non-phos-
phorylated NF-H, most strongly stained layers III, V and VI (Fig.
3I,J). Like SMI-32 and FNP-7, N200 stained apical and basal
Figure 2. Labeling of layer V pyramidal cells by fluorescent latex microsphere
injections into the spinal cord, superior colliculus and contralateral cortex hemisphere.
Injection sites into the (A) spinal cord, (E) superior colliculus and (I) primary
somatosensory cortex on coronal sections (indicated by arrows; white-green
appearance) counterstained with bisbenzimide (blue appearance). Coronal cortical
sections show microsphere labeling of pyramidal neurons after retrograde transport (B,
C, F, G, J, K). Sections were counterstained with bisbenzimide to reveal the
cytoarchitecture for cortical layer identification (D, H, L). (B) Neurons projecting to the
spinal cord were labeled and (D) were restricted to layer V. (C) A confocal image of
fluorescent microbeads contained in layer V pyramidal neurons taken from B after a
spinal cord injection. (F) superior colliculus injections label pyramidal neurons in the
ipsilateral cortex and (H) were also exclusively found in layer V. (G) A confocal image of
fluorescent microbead labeled neurons taken from F after a superior colliculus injection.
(J) Pyramidal neurons projecting to the contralateral cortex hemisphere through the
corpus callosum and (L) were located in all cortical layers except layer I. Layers II, III and
V showed the greatest number of cells projecting to the contralateral cortex. (K) A
confocal image of layer V neurons labeled with fluorescent microbeads taken from J
after a contralateral cortex injection. (D, H, L) Images were taken from the same field
shown in B, F and J with a UV filter. Scale bars = 2 mm (A, E, I); 1 mm (B, D, F, H, J,
L); 20 µm (C, G, K).
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dendrites as well as a few thick axons (Fig. 3K,L). Immuno-
staining from all three neurofilament markers indicated that
the majority of stained fibers that exited the cortex entered the
cortical white matter and turned laterally toward the internal
capsule (not toward the corpus callosum). Nevertheless,
strongly immunoreactive fibers were observed within the
corpus callosum itself and layers II–III consistently showed a
very small percentage of contralateral cortex projecting cells
which contained both green microspheres and stained with
one of the three neurofilament antibodies (average ± SEM; SMI-
32 = 2.31 ± 0.58; N200 = 8.89 ± 2.27; FNP-7 = 1.74 ± 0.39).
Other fiber tracts — including the cerebral peduncle and the
optic tract — as well as the thalamic reticular nucleus were also
heavily stained. A sizable percentage of corticocortical neurons
projecting to ipsilateral cortical areas showed neurofilament
reactivity (SMI-32 = 21.8% and FNP-7 = 61%). This finding
suggests that a large proportion of the cells that establish intra-
cortical connections also express SMI-32 and FNP-7; therefore,
these markers are not restricted to the longer-range inter-
cortical and subcortical projection neurons.
Quantification of Immunoreactive Layer V Pyramidal 
Cells Based on their Projection Sites
Markers Ubiquitously Expressed in all Three Subpopulations
Examined
Layer V pyramidal cells containing fluorescent microspheres
were quantified based on their immunoreactivity. Figure 4
shows confocal images of the three cell populations (contralat-
eral cortex, superior colliculus and spinal cord projecting)
stained with NR1, NR2a/b, PLCβ1, BDNF, NGF and TrkB anti-
bodies. The panels illustrate that all six antibodies co-localized
with the pyramidal cells that contained fluorescent micro-
spheres labeled from the spinal cord, superior colliculus and
contralateral cortex. The percentage of double-labeled cells
compared to the total number of cells counted (fluorescent-
labeled only plus double-labeled) was calculated. Regardless of
their projection site, a very high percentage of back-labeled
layer V pyramidal cells expressed NR-1, NR2a/b, PLCβ1, BDNF,
NGF and TrkB (Table 2). There was no significant difference
between the expression of these six proteins in the three
pyramidal cell populations.
Figure 3. Laminar distribution of neurofilament protein immunoreactivity in the
primary somatosensory cortex. (A–D) SMI-32, (E–H) FNP-7 and (I–L) N200 all showed
an intense staining pattern in layers II–III, V, and VI. (C, D) Higher magnifications of layer
V pyramidal cells showed SMI-32 immunoreactivity on the soma and apical and basal
dendrites. (G, H) High power confocal images of layer V neurons immunoreactive for
FNP-7. (K, L) Higher magnification of N200 immunoreactive layer V neurons. Scale bars
= 1 mm (A, B, E, F, I, J); 100 µm (C, G, K); 20 µm (D, H, L).
Figure 4. Detection of immunoreactivity in layer V pyramidal cell populations back-
labeled from three different targets. Confocal microscopic images of layer V pyramidal
neurons showing labeling with latex fluorescent microspheres (green) and
immunostaining (red) for various antigens after labeling from the spinal cord (A, D, G, J,
M, P), superior colliculus (B, E, H, K, N, Q) and contralateral cortex (C, F, I, L, O, R).
(A–C) NR1, (D–F) NR2a/b, (G–I) PLCβ1, (J–L) BDNF, (M–O) NGF and (P–R) TrkB
antibodies. All six of these antibodies produced staining on layer V neurons containing
retrogradely transported microspheres (arrows). In the adult rat neocortex, these
selected proteins were expressed in all three subpopulations of layer V pyramidal cells:
that is, neurons with projections to the spinal cord, superior colliculus and contralateral
cortex. Scale bar = 20 µm.
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Markers Specific for Subcortically Projecting Pyramidal
Neurons (SMI-32, FNP-7 and N200)
Figure 5 shows confocal images of the three cell populations
(contralateral cortex, superior colliculus and spinal cord
projecting) stained with three antibodies (SMI-32, N200 and
FNP-7) that are specific for different neurofilament epitopes.
The panels demonstrate that SMI-32, N200 and FNP-7 were
expressed in neurons projecting to the spinal cord and to the
superior colliculus, but these three antigens were not
expressed in the neurons projecting through the corpus
callosum to the contralateral hemisphere. Sections stained
with these three antibodies were analyzed using the same
quantification technique described above. Most of the subcor-
tical projecting pyramidal cells expressed SMI-32 (mean ± SEM;
spinal cord = 97.35 ± 1.33%; superior colliculus = 98.27 ±
0.007%), N200 (spinal cord = 98.08 ± 1.04%; superior colliculus
= 98.24 ± 1.00%) and FNP-7 (spinal cord = 98.27 ± 0.46%; supe-
rior colliculus = 97.99 ± 1.01%; Table 2). There was no signifi-
cant difference between the percentage of cells expressing
these three neurofilament markers in the subcortical
projecting neurons. However, the contralateral cortex
projecting cells barely expressed a quantifiable level of these
neurofilament markers (SMI-32 = 1.06 ± 0.54%; N200 = 2.10 ±
1.36%; FNP-7 = 0.33 ± 0.33%; Table 2). The percentage differ-
ence between neurofilament expression in callosal —
compared to subcortical — projecting neurons was statistically
significant (Table 2).
Neurofilament Protein Expression in Organotypic 
Culture
We performed two experiments to determine the likelihood
that the neurofilament immunoreactivity in layer V projection
neurons is elicited and maintained by their subcortical targets
through their specific axonal projections. We prepared cortical
slices from the parietal cortex of E16 embryos and maintained
them in organotypic cultures for two weeks (Fig. 1B) to test if
layer V neurons express SMI-32 and FNP-7 while developing
Table 2
Proportion of the double-labeled layer V projection neurons back-labeled from different targets and stained with various antibodies
n = 3 adult rats for each injection paradigm (spinal cord, superior colliculus and contralateral cortex). All layer V neurons containing green fluorescent microspheres in each slice were counted (‘Total’ 
column). The numbers of layer V cells that contained green fluorescent microspheres and double-labeled with a given antibody (DLN column) were quantified. The percentage of DLN for each animal was 
calculated. The percentages were averaged and the standard error of the mean was calculated (‘Av. %DLN ± SEM’ column). Note that ∼100% of the spinal cord, superior colliculus and contralateral cortex 
projecting neurons expressed NR1, NR2a/b, PLCb1, BDNF, NGF and TrkB. The difference between the three populations of cells was not statistically significant for these antibodies. However, the 
immunoreactivity for the neurofilament markers (SMI-32, N200 and FNP-7) was selectively expressed in subcortical projecting cells (i. e. projecting to the spinal cord and superior colliculus). Virtually none 
of the contralateral cortex projecting neurons expressed these three neurofilament markers. The difference between the subcortical and callosal projecting cells was statistically significant. SMI-32 SpC 
versus CC (P = 0.00038); SMI-32 SC versus CC (P = 0.00014); N200 SpC versus CC (P = 0.00025); N200 SC versus CC (P = 0.00042); FNP-7 SpC versus CC (P = 0.0000024); FNP-7 SC versus CC (P
= 0.00016). Abbreviations: Av. %DL, average percentage of double-labeled layer V neurons quantified; CC, contralateral cortex projecting neurons; DLN, double-labeled layer V neuron; Total, total number 
of layer V neurons quantified; SC, superior colliculus projecting neurons; SEM, standard error of the mean; SpC, spinal cord projecting neurons.
Spinal cord Superior 
colliculus
Contralateral 
cortex
Antigen DLN Total Av. %DLN ± SEM DLN Total Av. %DLN ± SEM DLN Total Av. %DLN ± SEM
NR1 218 222 98.67 ± 1.33 208 212 98.16 ± 1.11 223 224 99.37 ± 0.66
NR2a/b 197 198 99.73 ± 0.27 261 266 97.87 ± 0.70 273 275 99.28 ± 0.36
PLCb1 165 168 98.65 ± 1.53 248 255 97.37 ± 1.78 223 227 98.21 ± 0.96
BDNF 207 207 100.00 ± 0.00 354 357 99.31 ± 0.38 243 244 99.63 ±0.37
NGF 179 180 99.57 ± 0.42 372 374 99.64 ± 0.36 229 230 99.48 ± 0.52
TrkB 165 165 100.00 ± 0.00 248 250 98.86 ± 0.60 265 269 98.48 ± 0.96
SMI-32 154 159 97.35 ± 1.33 285 290 98.27 ± 0.01 2 219 1.06 ± 0.54
N200 270 275 98.08 ± 1.04 190 195 98.24 ± 1.00 5 312 2.10 ± 1.36
FNP-7 205 209 98.27 ± 0.46 244 246 97.99 ± 1.01 3 291 0.33 ± 0.33
Figure 5. Confocal microscopic images of layer V pyramidal neurons showing that the
three neurofilament antibodies (red) specifically stained neurons that project
subcortically, but they did not stain cells with projections to the contralateral cortex (all
populations contain green microspheres). SMI-32 (A, B), N200 (D, E) and FNP-7 (G, H)
were specifically located in the spinal cord (A, D, G) and superior colliculus (B, E, H)
projecting layer V neurons (arrows indicate examples of double-labeling). (C, F, I)
contralateral cortex projecting neurons (green microspheres indicated by arrowheads),
did not express SMI-32 (C), N200 (F) or FNP-7 (I). The open arrow heads indicate
neurons expressing the neurofilaments, but do not contain green microspheres and
thus do not project to the contralateral cortex. Scale bar = 20 µm.
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without contact with their target tissues. The slices derived
from the embryonic cortex did, in fact, express SMI-32 (Fig.
6A) and FNP-7 (Fig. 6B). In high power images, layer V pyram-
idal neurons were clearly identified by strong SMI-32 (Fig. 6C)
and FNP-7 (Fig. 6D) immunoreactivity. Layers II and III did not
develop as well as the other layers, which is a typical observa-
tion in embryonic explants grown in culture (Molnár and
Blakemore, 1999).
To further investigate whether or not subpopulations of
layer V neurons maintain their SMI-32 and FNP-7 immunoreac-
tivity specificity in the absence of contact with their target
tissue, pyramidal cells were pre-labeled and cortical slices were
cultured. At P3, after the corticofugal projections had reached
the superior colliculus and the contralateral cortex, fluores-
cent latex microspheres were injected into one of these
targets. At P4, cortical slice cultures were prepared from
regions containing labeled cells. These slices were cultured in
isolation for two weeks, then fixed and immunostained for
FNP-7 and SMI-32 without resectioning (Fig. 7). In 40 cultures,
individual microsphere-labeled layer V neurons (n = 1163)
were examined for immunohistochemistry. Of the 320 layer V
cells that were labeled from the contralateral hemisphere
(Fig. 7), only a small percentage (mean ± SEM; 1.69 ± 1.40)
expressed SMI-32. In contrast, of the 196 layer V cells that were
labeled from the superior colliculus (Fig. 7), a much higher
percentage (27.11 ± 4.67) of labeled cells were SMI-32
immunoreactive. Of the 286 layer V neurons that were labeled
from the contralateral cortex (Fig. 7), only 4.2% were FNP-7
immunoreactive, whereas 44.6% of layer V neurons (n = 361)
that were labeled from the superior colliculus were immuno-
reactive (Fig. 7). Laminar specificity of neurofilament immuno-
reactivity was also maintained with stronger staining in layers
II, III, V and VI (Fig. 7). Although the absolute number of
double-labeled neurons in the cultures was decreased, the
overall pattern of neurofilament expression was consistent
with the in vivo observations.
Discussion
Differential Protein Expression in Layer V Pyramidal 
Cell Subpopulations
In this study, a combination of retrograde labeling and immu-
nostaining techniques were used to determine whether or not
subpopulations of layer V pyramidal cells projecting to distinct
Figure 6. Organotypic cultures of E16 rat cortices express SMI-32 and FNP-7
immunoreactivity in their layer V pyramidal neurons after 2 weeks in vitro. The presence
of SMI-32 and FNP-7 immunoreactive layer V neurons suggests that the expression of
these neurofilaments does not depend on the presence of the subcortical target
tissues. (A) SMI-32 was expressed in layer V pyramidal neurons in vitro. (C) Higher
magnification of neurons taken from A. (B) FNP-7 was expressed in layer V pyramidal
neurons in vitro. (D) Higher magnification of neurons taken from B. Scale bars = 1 mm
(A, B); 100 µm (C, D).
Figure 7. The subpopulation-specific expression of SMI-32 and FNP-7 immunoreactivity is maintained in organotypic cortical cultures from postnatal rats after 2 weeks in vitro.
Layer V pyramidal neurons were back-labeled from the contralateral cortex (see inserts in A, C) or from the superior colliculus (see inserts in E, G) at P3 (both populations contain
green microspheres). At P4, the somatosensory cortex of both groups was cultured for 2 weeks. SMI-32 and FNP-7 maintained a laminar (A, C, E, G) pattern of expression similar
to that found in vivo. This suggests that the presence of specific targets is not necessary for the maintenance of the particular layer V populations after P4. (B, D) Confocal images
of pyramidal cells taken from A and C respectively. Both SMI-32 (B) and FNP-7 (D) failed to co-localize with contralateral cortex projecting neurons (green microspheres indicated
by the arrowheads). (F, H) Confocal images of pyramidal cells taken from E and G respectively. A large percentage of both SMI-32 (F) and FNP-7 (G) co-localized with superior
colliculus projecting neurons (indicated by the arrows). P, postnatal day. Scale bars = 1 mm (A, C, E, G); 20 µm (B, D, F, H).
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targets show differential expression of antigens known to be
located in layer V of adult rats. These antigens include the
following: NR1, NR2a/b, PLCβ1, BDNF, NGF, TrkB, SMI-32,
FNP-7 and N200. Staining patterns found in this study confirm
previous observations with the same antibodies: NR1 (Aoki et
al., 1994), NR2a/b (Conti et al., 1999), TrkB (Tongiorgi et al.,
1999; Miller, 2000), NGF (Miller, 2000), BDNF (Murer et al.,
1999), SMI-32 (Hof and Morrison, 1995; Gabernet et al., 1999),
FNP-7 (Hornung and Riederer, 1999) and N200 (Sasaki and
Maruyama, 1994). However, these experiments show for the
first time a striking difference in neurofilament expression
(SMI-32, FNP-7 and N200) between subcortical (superior collic-
ulus and spinal cord projecting type I neurons) and contralat-
eral cortex (type II neurons) projecting neurons. While a large
proportion of spinal cord and superior colliculus projecting
neurons were heavily immunoreactive for the neurofilament
antigens (SMI-32, FNP-7 and N200), a visual assessment indi-
cated that none of the callosal projecting layer V cells had
significantly detectable immunoreactivity. In contrast, all of
the other proteins tested (NR1, NR2a/b, PLCβ1, BDNF, NGF
and TrkB) were expressed equally in the layer V pyramidal
subpopulations examined.
Differential Neurofilament Expression Layer V 
Pyramidal Neuron Subpopulations
Neurofilaments (NF), which are part of the intermediate fila-
ment family, are one of the earliest recognizable features of the
developing central nervous system (Ulfig et al., 1998). Neurofil-
aments are heteropolymers consisting of three subunit
proteins: NF-L (68 kDa), NF-M (150 kDa) and NF-H (200 kDa)
(Hoffman and Lasek, 1975; Nixon and Sihag, 1991; Nixon,
1998). These subunits combine to form filaments (∼10 nm
diameter). All triplets consist of two structural domains: an α-
helical domain, which is the functional backbone and a
carboxy end. The carboxy terminals vary in their amount of
phosphorylation, which is responsible for the different molec-
ular weights (Shaw, 1991). Decreases in neurofilament expres-
sion or abnormal neurofilament phosphorylation have been
implicated in normal aging (Vickers et al., 1992; Budinger et
al., 2000) as well as in neurological diseases (Bickford et al.,
1998) such as: Alzheimer’s disease (Morrison et al., 1987; Hof
et al., 1990; Hof and Morrison, 1990; Trojanowski et al., 1993;
Vickers et al., 1994; Bussière et al., 2003a,b), Parkinson’s
disease (Goldman et al., 1983), Pick’s disease (Perry et al.,
1987), amyotrophic lateral sclerosis (Manetto et al., 1988;
Munoz et al., 1988; Mizusawa et al., 1989; Tsang et al., 2000),
traumatic brain injury (Saatman et al., 1998) and multiple scle-
rosis (Trapp et al., 1998).
Neurofilaments have a very specific laminar distribution
pattern in the cortex that reflects the functional and anatom-
ical brain divisions. Therefore, neurofilament staining is a
powerful tool for confirming and extending previous architec-
tural observations (Hof et al., 1995; Preuss et al., 1997; Geyer
et al., 2000). SMI-32 recognizes the non-phosphorylated NF-H
form, N200 recognizes the non-phosphorylated and phosphor-
ylated NF-H forms and FNP-7 recognizes the non-phosphor-
ylated NF-M form. These protein epitopes initially appear at P7,
which interestingly coincides with the divergence of the layer
V pyramidal neuronal subpopulations with respect to their
somatodendritic morphologies (Riederer and Matus, 1985;
Riederer, 1995; Riederer et al., 1995; Kogan et al., 2000).
It is important to relate the onset of neurofilament expres-
sion to other aspects of layer V pyramidal cell development.
Neurons from layer V subpopulations are born around E15–18
and migrate to layer V by E19–20 (Miller, 1988). Morphologic-
ally, they initially appear indistinguishable: all have stout apical
dendrites with terminal tufts in layer I and they do not fire
action potential bursts in response to depolarizing current
(Kasper et al., 1994). Shortly after reaching layer V, they begin
extending their axons toward different targets. The callosal
axons start to cross the corpus callosum at E16–18, whilst the
corticofugal axons enter the internal capsule at E17 and enter
the cerebral peduncle at E19. The axons reach the basal pons
at E19 and the superior colliculus and spinal cord shortly after
birth (De Carlos and O’Leary, 1992). Axonal target invasion
occurs postnatally. It is only after axonal outgrowth that the
dendritic morphologies begin to diverge (P5; Koester and
O’Leary, 1992). The different electrophysiological properties
are first detected much later (P14; Kasper et al., 1994). These
findings raise the question: how do seemingly similar cell
populations differentiate into a heterogeneous group with
different targets?
It is not clear what causes these morphological changes, but
it has been shown that neurofilaments participate in the struc-
tural organization and stabilization of dendrites (Riederer and
Matus, 1985; Riederer et al., 1995; Kogan et al., 2000). There-
fore, the neurofilament quantity may be important in estab-
lishing and maintaining different morphologies of layer V
neuronal subpopulations; therefore, playing a role in connec-
tions reaching their developmental endpoint (Liu et al., 1994;
Kogan et al., 2000).
Previous studies in macaque monkeys have shown that SMI-
32 is differentially expressed in certain subpopulations of
pyramidal cells. These studies have exclusively examined
corticocortical — not subcortical — projecting neurons in layers
II, III, V and VI. The corticocortical neuron populations that
express low levels of SMI-32 include cells that project from the
anterior cingulate to prefrontal cortex; from prefrontal to
prefrontal cortex; and from V1, V2 or V3 to V4 (Campbell et
al., 1991; Hof et al., 1995, 1996b). Corticocortical neuron
populations that express high levels of SMI-32 include cells
that project from polysensory association cortices (superior
temporal sulcus) to prefrontal cortices and from V1, V2, V3 to
MT (Campbell et al., 1991; Hof et al., 1995, 1996b). Equal
numbers of corticocortical neurons that send their projections
from high level visual association cortex (intraparietal sulcus)
to prefrontal cortex express SMI-32 (Campbell et al., 1991).
Our results confirm previous findings in rats, which show that
somatomotor corticocortical pyramidal neurons in layers III
and V projecting contralaterally express very low levels of SMI-
32 (Kirkcaldie et al., 2002). One must, therefore, take into
account that SMI-32 specificity may vary between primate and
non-primate species.
Several studies have correlated the neurofilament amount
or type with specific cellular populations in order to better
understand the functional significance of each cell type. It is
known that the amount of neurofilament increases with the
increase of the cell size (Campbell and Morrison, 1989; Tsang
et al., 2000); therefore, layer V projection neurons would be
expected to have high neurofilament levels compared to other
cortical layers. Campbell and Morrison (1989) first showed that
non-phosphorylated neurofilaments are found in neurons with
long axonal projections extending to cortical and subcortical
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areas. This finding is supported by studies that show high
neurofilament levels in: long distance ipsilateral and contralat-
eral cortex projections (Campbell et al., 1991), long ipsilateral
association connections of the visual system (Hof et al., 1996a),
large retinal ganglion cells (Straznicky et al., 1992) and long
corticofugal projections (Hornung and Riederer, 1999). Few
cells having short corticocortical, callosal or limbic projections
express neurofilament epitopes (Hof et al., 1995, 1996a;
Hornung and Riederer, 1999). Our observations demonstrate
that layer V pyramidal neurons with callosal (type II) projec-
tions do not express these selected neurofilament epitopes, in
spite of their long axons. However, it has been suggested that
the neurofilament amount might not be associated with axonal
length. Instead, the neurofilament quantity might be associated
with the amount of axonal myelination (Kirkcaldie et al.,
2002). The degree of myelination corresponds with the projec-
tion target and would explain the contradictions between the
different neurofilaments in ipsilateral connections and callosal
connections. Cortical projections extending to subcortical
targets and projections from primary sensory cortex extending
to association areas (heterotopic) have heavily myelinated
axons and are integral for important cognitive and motor
processing. Goldstein et al. (1987) found that NF-H protects
against proteolysis, thus increasing structural stability, which is
critical in large, fast-conducting neurons. In addition to micro-
tubules, neurofilaments have been implicated in regulating the
nutrient transport rate, which is especially important in main-
taining the structural integrity of these large neurons (Lasek,
1988).
We investigated whether these two distinct classes of layer V
cells preserve their neurofilament specificity in two different
organotypic slice culture paradigms, in which the projection
neurons have been axotomized and lack contact with their
targets. When E16 cortical slices were cultured for 2 weeks,
SMI-32 and FNP-7 immunoreactive cells were still present,
suggesting that the subpopulation phenotype is not dependent
upon the target and is an inherent property of neurons. Obvi-
ously, before the connections reach their target, the back-labe-
ling of selective layer V subpopulations is not possible;
therefore, the issue of subpopulation specificity cannot be
addressed with the techniques used in the current study at this
embryonic stage. However, maintenance of subpopulation
neurofilament specificity in the absence of target tissue contact
can be addressed at later developmental stages. In this study,
we demonstrated that after 2 weeks of culturing P4 slices, the
overall pattern of SMI-32 and FNP-7 immunoreactivity was
consistent with the in vivo observations. The pyramidal
neurons labeled from the superior colliculus at P3 maintained
specific expression of SMI-32 and FNP-7, but neurons labeled
from the contralateral cortex hemisphere did not express these
epitopes. These findings suggest that whilst the specific
subpopulation phenotype development normally occurs once
the axons have innervated their targets, this process is not
dependent upon those targets. Therefore, it stands to reason
that by P4, the two layer V neuronal subpopulations might
already be committed to different differentiation programs
which continue in the absence of their target tissue contact.
In summary, this study demonstrates that layer V neuronal
subpopulations not only have specific projection targets and
somatodendritic morphologies, but also express different
structural protein levels recognized by SMI-32, NFP-7 and N200
antibodies. The finding that neurofilament proteins are
expressed in subcortical (superior colliculus and spinal cord
type I) projecting neurons (but not in type II, homotopic
callosal projecting cells) that have large dendritic tufts
supports theories that neurofilaments are associated with
dendritic arborizations, long projecting axons and axons with
a high degree of myelination. The characterization of molec-
ular and cellular differences in adult rat layer V neuronal
subpopulations sheds light on the mechanisms involved in
functional circuit differentiation in mammalian cerebral cortex
development. The specific neurofilament expression in certain
neuronal populations, even in the absence of long projections
and maintenance after distant target removal through slice
culturing, suggests that early in corticogenesis, neuronal
subpopulations are already committed to distinct protein
expression patterns.
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